UBS Group’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.23M Buy
43,700
+100
+0.2% +$21.5K ﹤0.01% 3445
2025
Q4
$8.96M Buy
43,600
+8,900
+26% +$1.67M ﹤0.01% 3406
2025
Q3
$5.45M Buy
34,700
+32,800
+1,726% +$5.07M ﹤0.01% 3947
2025
Q2
$319K Sell
1,900
-1,300
-41% -$193K ﹤0.01% 6394
2025
Q1
$441K Sell
3,200
-28,800
-90% -$3.67M ﹤0.01% 5950
2024
Q4
$3.78M Hold
32,000
﹤0.01% 4121
2024
Q3
$3.54M Hold
32,000
﹤0.01% 3423
2024
Q2
$3.15M Buy
32,000
+2,000
+7% +$204K ﹤0.01% 3302
2024
Q1
$3.36M Buy
+30,000
New +$3.24M ﹤0.01% 3394
2020
Q3
Sell
-6,800
Closed -$355K 8005
2020
Q2
$355K Sell
6,800
-8,500
-56% -$438K ﹤0.01% 4395
2020
Q1
$733K Buy
+15,300
New +$794K ﹤0.01% 3630
2019
Q2
Sell
-64,600
Closed -$3.11M 7866
2019
Q1
$3.11M Buy
64,600
+52,100
+417% +$2.61M ﹤0.01% 2597
2018
Q4
$558K Buy
+12,500
New +$652K ﹤0.01% 4176
2017
Q4
Sell
-7,500
Closed -$502K 7845
2017
Q3
$502K Buy
+7,500
New +$530K ﹤0.01% 4213
2017
Q1
Sell
-44,100
Closed -$3.17M 7650
2016
Q4
$3.17M Sell
44,100
-10,200
-19% -$737K ﹤0.01% 2506
2016
Q3
$4.22M Buy
54,300
+38,200
+237% +$3.09M ﹤0.01% 2175
2016
Q2
$1.26M Buy
+16,100
New +$1.28M ﹤0.01% 3176
2015
Q3
Sell
-33,500
Closed -$2.8M 8414
2015
Q2
$2.8M Buy
+33,500
New +$2.96M ﹤0.01% 2650
2015
Q1
Sell
-1,900
Closed -$153K 8847
2014
Q4
$153K Buy
+1,900
New +$150K ﹤0.01% 5289

Other funds holding CAH

UBS Group's CAH Position: Q1 2026 in Review

UBS Group reduced its Cardinal Health (CAH) stake by 13% in Q1 2026, selling an estimated $27.8M and leaving 839,569 shares worth $177M. The position accounts for 0.03% of the portfolio, ranked #671.

UBS Group first reported a position in CAH in Q4 2014 and has held it in 46 quarters since. The position peaked at $199M in Q4 2025. 1,424 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • UBS Group held 839,569 shares of Cardinal Health worth $177M as of Q1 2026.
  • UBS Group sold 129,278 Cardinal Health shares in Q1 2026, an estimated $27.8M.
  • Cardinal Health made up 0.03% of UBS Group's portfolio in Q1 2026, its #671 holding.
  • UBS Group first reported a position in Cardinal Health in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's Cardinal Health position peaked at $199M in Q4 2025.
  • 1,424 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.